D. Cooper, J. Moisan, B. Abdous, and J.-P. Grégoire, “A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA”, J Popl Ther Clin Pharmacol, vol. 15, no. 3, Dec. 2018, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/229